Tumor persistence and regression in skin carcinogenesis. An experimental study

Area of Science:

• Carcinogenesis
• Dermatology
• Toxicology

Background:

• Skin tumors can spontaneously regress, a phenomenon not fully understood.
• The multi-step nature of neoplastic transformation requires further investigation.

Purpose of the Study:

• To investigate the impact of different 7,12-dimethylbenzanthracene (DMBA) and phorbolester treatment regimens on skin tumor development and regression in mice.
• To elucidate the relationship between carcinogen exposure patterns and tumor behavior.

Main Methods:

• Lifetime study involving Swiss mice.
• Application of single or repeated doses of 7,12-dimethylbenzanthracene (DMBA) and phorbolester.
• Observation and quantification of skin tumor incidence, regression, and duration.

Main Results:

• Single high-dose DMBA or DMBA with phorbolester induced numerous skin tumors, many regressing spontaneously, particularly early in the experiment.
• Repeated low-dose DMBA induced more tumors with fewer, transient regressions, often in animals with persistent tumors.
• Tumor regression incidence showed limited correlation with tumor size, duration, or total tumor number.

Conclusions:

• Carcinogen treatment regimen significantly influences the incidence and biological behavior of induced skin tumors.
• Skin tumor development involves multiple neoplastic transformation steps, from hyperplasia to malignancy, with varying regression rates.
• Tumor regression is a complex process influenced by carcinogen exposure and tumor characteristics.